Tukysa 150 MG tablet UU 60S
Ended Awarded
- Contract number
- SPE2DB25FJU41
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,337
Award facts
- Contract value 100% obligated
- $6,337.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,337.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TUKYSA 150 mg tablets (60-count units) on September 5, 2025, with an ultimate completion date of September 26, 2025. This non-competitive, non-set-aside award represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TUKYSA (tucatinib) is an oral tyrosine kinase inhibitor used in oncology treatment, reflecting the breadth of specialty pharmaceuticals AmerisourceBergen supplies to federal healthcare systems.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for military and veteran healthcare needs through its comprehensive DLA contract vehicle, which enables the company to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's established track record of competitively awarded federal contracts demonstrates its capability to fulfill federal medical procurement requirements efficiently, supporting the broader DLA medical supply chain mission of providing pharmaceuticals and medical commodities to military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB25FJU41?
SPE2DB25FJU41 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FJU41 worth?
The government has obligated $6,337 on SPE2DB25FJU41.
Is contract SPE2DB25FJU41 an order under another contract?
Yes. SPE2DB25FJU41 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJU41 competed?
The extent of competition for SPE2DB25FJU41 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award